The complex treatment process of CAR T therapies requires a life sciences commercial teams to take a unique approach to product launches. In Med Ad News, Dennis Fournogerakis and Nathaniel Swenson describe the strategic approach commercial teams should take to ensure innovative, new CAR T treatments quickly reach patients in need.